ABVC BioPharma Inc. (ABVC)
NASDAQ: ABVC
· Real-Time Price · USD
3.04
-0.05 (-1.62%)
At close: Aug 21, 2025, 3:59 PM
3.07
0.99%
Pre-market: Aug 22, 2025, 07:00 AM EDT
ABVC BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 391.24K | 508.38K | 509.59K | 509.79K | 136.4K | 25.36K | 152.43K | 739.26K | 765.64K | 1.07M | 969.78K | 343K | 399.73K | 118.31K | 355.8K | 455.78K | 472.34K | 667.41K |
Cost of Revenue | 197.13K | 116.48K | 2.81K | 139.97K | 169.29K | 242.08K | 302.04K | 428.24K | 409.37K | 344.75K | 286.42K | 23.81K | 13.46K | 5.74K | 5.09K | 4.19K | 12.41K | 16K |
Gross Profit | 196.17K | 393.95K | 508.83K | 369.86K | -32.85K | -216.67K | -149.57K | 311.02K | 356.27K | 727.64K | 683.37K | 319.19K | 386.27K | 112.57K | 350.71K | 451.6K | 459.93K | 651.41K |
Operating Income | -3.27M | -1.95M | -4.1M | -5.73M | -7.93M | -9.15M | -8.22M | -9.39M | -10.95M | -10.8M | -15.11M | -18.43M | -16.68M | -16.67M | -11.71M | -10.11M | -9.43M | -8.59M |
Interest Income | 94.38K | 102.38K | 87.36K | 112.93K | 108.92K | 136.82K | 185.48K | 208.46K | 216.38K | 200.35K | 187.82K | 127.35K | 88.52K | 60.23K | 72.58K | 103.99K | 114.23K | 112.85K |
Pretax Income | -3.26M | -2.33M | -4.32M | -7.6M | -10.83M | -11.68M | -10.65M | -11.04M | -11.44M | -11.24M | -15.51M | -17.87M | -16.06M | -16.14M | -11.21M | -10.38M | -10.59M | -10.71M |
Net Income | -3.06M | -1.81M | -3.8M | -7.14M | -10.28M | -11.53M | -10.52M | -12.27M | -12.66M | -12.25M | -16.42M | -19.49M | -17.59M | -17.71M | -12.84M | -9.76M | -9.79M | -9.67M |
Selling & General & Admin | 1.96M | 2.32M | 4.43M | 5.87M | 7.57M | 8.13M | 7M | 7.21M | 8.66M | 8.86M | 13.1M | 17.29M | 15.65M | 15.54M | 11.05M | 9.63M | 9.09M | 8.66M |
Research & Development | 131.94K | 139.07K | 179.27K | 219.48K | 322.96K | 797K | 1.06M | 2.49M | 2.65M | 2.67M | 2.69M | 1.46M | 1.42M | 1.24M | 1M | 926.9K | 797.98K | 578.18K |
Other Expenses | 1.49M | 599.00 | 599.00 | 414.00 | 104.00 | -495 | -495 | -310 | 22.09K | 4.43K | 19.14K | 19.14K | 474.00 | 18.13K | 9.96K | 14.41K | 16.8K | 16.8K |
Operating Expenses | 3.58M | 2.46M | 4.61M | 6.09M | 7.89M | 8.92M | 8.06M | 9.7M | 11.31M | 11.53M | 15.8M | 18.75M | 17.07M | 16.78M | 12.06M | 10.56M | 9.89M | 9.24M |
Interest Expense | -25.26K | 364.18K | 825.9K | 2.27M | 3.27M | 3.12M | 2.49M | 1.52M | 432.41K | 332.42K | 293.97K | 159.51K | 71.65K | 139.56K | 251.58K | 368.26K | 345.89K | 403.74K |
Selling & Marketing Expenses | n/a | n/a | n/a | -7.58K | -7.58K | -7.58K | -7.58K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.3M | 2.3M | 2.3M |
Cost & Expenses | 3.66M | 2.46M | 4.61M | 6.24M | 8.07M | 9.17M | 8.37M | 10.13M | 11.71M | 11.87M | 16.08M | 18.77M | 17.08M | 16.79M | 12.06M | 10.57M | 9.9M | 9.26M |
Income Tax Expense | 23.98K | -110.64K | -4.04M | -3.87M | -3.87M | -3.68M | 256.01K | 1.04M | 1.05M | 884.64K | 797.78K | 845.9K | 766.01K | 788.9K | 824.75K | -272.66K | -241.73K | -230.81K |
Shares Outstanding (Basic) | 17.39M | 14.97M | 13.2M | 12.41M | 11.32M | 9.74M | 4.2M | 4.05M | 3.31M | 3.31M | 3.31M | 3.26M | 3.13M | 2.97M | 2.51M | 2.58M | 2.44M | 2.44M |
Shares Outstanding (Diluted) | 17.39M | 14.97M | 13.2M | 12.41M | 11.32M | 9.74M | 6.68M | 4.05M | 3.31M | 3.31M | 3.31M | 3.26M | 3.13M | 2.97M | 2.51M | 2.69M | 2.44M | 2.44M |
EPS (Basic) | -0.18 | -0.14 | -0.38 | -0.45 | -1.26 | -1.85 | -2.11 | -3.52 | -3.84 | -3.75 | -5.2 | -6.89 | -6.45 | -6.67 | -5.13 | -4.41 | -4.66 | -4.8 |
EPS (Diluted) | -0.18 | -0.14 | -0.38 | -0.45 | -1.26 | -1.85 | -2.11 | -3.52 | -3.84 | -3.75 | -5.2 | -6.89 | -6.42 | -6.63 | -5.09 | -4.31 | -4.59 | -4.74 |
EBITDA | -2.5M | -1.32M | -3.35M | -5.71M | -7.94M | -8.94M | -8.13M | -9.49M | -10.98M | -10.88M | -15.2M | -17.71M | -15.99M | -16.01M | -10.97M | -9.99M | -10.22M | -10.28M |
EBIT | -2.69M | -1.63M | -3.66M | -5.84M | -8.07M | -9.07M | -8.16M | -9.51M | -11.01M | -10.91M | -15.22M | -17.73M | -16.01M | -16.02M | -10.98M | -10.01M | -10.24M | -10.31M |
Depreciation & Amortization | 381.11K | 313.58K | 302.18K | 130.45K | 130.89K | 124.58K | 28.53K | 27.38K | 26.39K | 24.88K | 23.8K | 20.63K | 17.03K | 14.48K | 11.99K | 15.54K | 21.41K | 28.9K |